Status:
COMPLETED
Taking Into Account the Patient/Parent Preference in the Galenic Choice in Atopic Dermatitis. Feasibility and Impact on Treatment Adherence
Lead Sponsor:
Nantes University Hospital
Conditions:
Atopic Dermatitis
Eligibility:
All Genders
3-15 years
Brief Summary
Atopic dermatitis is a chronic inflammatory skin disease often occurring in childhood. The treatment consists in making daily local treatment with topical steroid on inflammatory lesions and emollien...
Detailed Description
Day 0 : * Inclusion, collecting non-opposition * Presentation of the samples: 4 products presented in the same packaging (pump bottle 200 ml) and ranked in order of their fat content: * Cold Cream: 8...
Eligibility Criteria
Inclusion
- Patients experiencing treatment failure despite appropriate treatment. Patients minors aged between 3 and 15 years For children age 7 and non-autonomous children in the application of treatment, the parent at the initial consultation should be the one who treats the child.
- Information from both parents or parental authority and collection of Non-Opposition The patient must have a computer to do its PO-SCORAD between consultations. Patient who used a topical treatment for atopic dermatitis in the week preceding the study.
Exclusion
- Patient refusal to participate in the clinical study. Adults and children over 15 years.
Key Trial Info
Start Date :
October 14 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 31 2015
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT02193230
Start Date
October 14 2014
End Date
October 31 2015
Last Update
September 16 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU de Nantes
Nantes, France, 44093